The Cancer Genome Atlas Research Network: A Sight to Behold

Endocrine Pathology

Volumn 25, Issue 4, 2014, Pages 362-365

  Giordano, Thomas J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAF GENE; CANCER GENETICS; CANCER RESEARCH; CHROMOSOME REARRANGEMENT; EDITORIAL; EIF1AX GENE; FUNDING; GENE FUSION; GENOME; GENOMICS; HISTOPATHOLOGY; HUMAN; MEDICAL INFORMATICS; POINT MUTATION; QUALITY CONTROL; RET GENE; THYROID CARCINOMA; TISSUE SECTION; TUMOR GENE; BIOLOGY; BOOK; GENETICS; HUMAN GENOME; NEOPLASM;

COMPUTATIONAL BIOLOGY; GENOME, HUMAN; HUMANS; NEOPLASMS; REFERENCE BOOKS, MEDICAL;

EID: 84911808136     PISSN: 10463976     EISSN: 15590097     Source Type: Journal    
DOI: 10.1007/s12022-014-9345-4     Document Type: Editorial

References (14)

1. Cancer Genome Atlas Research N Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061–1068, 2008
2. Cancer Genome Atlas Research N Integrated genomic analyses of ovarian carcinoma. Nature 474: 609–615, 2011
3. Cancer Genome Atlas Research N Comprehensive genomic characterization of squamous cell lung cancers. Nature 489: 519–525, 2012.
4. Giordano TJ, Kuick R, Thomas DG et al. Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis. Oncogene 24: 6646–6656, 2005.
5. Giordano TJ, Au AY, Kuick R et al. Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation. Clinical cancer research: an official journal of the American Association for Cancer Research 12: 1983–1993, 2006.
6. Giordano TJ Genome-wide studies in thyroid neoplasia. Endocrinology and metabolism clinics of North America 37: 311–331, vii-viii, 2008.
7. Lloyd RV, Erickson LA, Casey MB et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. The American journal of surgical pathology 28: 1336–1340, 2004.
8. Elsheikh TM, Asa SL, Chan JK et al. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. American journal of clinical pathology 130: 736–744, 2008.
9. Duggal R, Rajwanshi A, Gupta N, Vasishta RK Interobserver variability amongst cytopathologists and histopathologists in the diagnosis of neoplastic follicular patterned lesions of thyroid. Diagnostic cytopathology 39: 235–241, 2011.
10. Gymrek M, McGuire AL, Golan D, Halperin E, Erlich Y Identifying personal genomes by surname inference. Science 339: 321–324, 2013.
11. Cancer Genome Atlas Research N Integrated Genomic Characterization of Papillary Thyroid Carcinoma. Cell 159, 2014.
12. Lawrence MS, Stojanov P, Polak P et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499: 214–218, 2013.
13. Chen KT, Rosai J Follicular variant of thyroid papillary carcinoma: a clinicopathologic study of six cases. The American journal of surgical pathology 1: 123–130, 1977.
14. Nikiforov YE, Carty SE, Chiosea SI et al. Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay. Cancer, 2014.